Quick Takeaways
- Enavate Sciences GP, LLC filed SCHEDULE 13D/A for CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP).
- Disclosed ownership: 6%.
- Date of event: 19 Dec 2025.
Enavate Sciences GP, LLC - 19 Dec 2025 SCHEDULE 13D/A Report for CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP)
- Filing Manager
- Enavate Sciences GP, LLC
- Reporting Manager
- Enavate Sciences GP, LLC
- Symbol
- CAMP
- Shares outstanding
- 52,122,667 shares
- Disclosed Ownership
- 3,127,360 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13D/A
- Filing time
- 23 Dec 2025, 17:58:09 UTC
- Date of event
- 19 Dec 2025
- Previous filing
- 15 Sep 2025
- Next filing
- 11 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Enavate Sciences GP, LLC disclosed 6% ownership in CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP) on 19 Dec 2025."
What Changed
- Previous schedule filing date: 15 Sep 2025.
- Current filing was accepted on 23 Dec 2025, 17:58.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Enavate Sciences GP, LLC | 6% | 3,127,360 | 0 | 3,127,360 | /s/ James P. Boylan | By James P. Boylan, Manager | 0001953107 |
| Everest Aggregator, LP | 6% | 3,127,360 | 0 | 3,127,360 | /s/ James P. Boylan | By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager | 0002040426 |